BioMarker Strategies
Baltimore
About BioMarker Strategies
BioMarker Strategies offers SnapPath, a live tumor cell testing platform that improves the treatment of cancer. BioMarker Strategies is a tissue-based cancer diagnostics company. It was founded in 2006 and is headquartered in Baltimore, Maryland.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $50K – $100K
- Total funding: $5.7M
- Last round: Series Unknown (Sep 2016)
- Website: biomarkerstrategies.com
- Phone: 4105221009
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/biomarker-strategies-194839 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.